# Enhanced Datamart

---

# Analyze key aspects of the patient journey with clinically deep oncology real-world data

Enhanced Datamarts (EDMs), are longitudinal, de-identified real-world dataset subscriptions sourced from electronic health records that are refreshed monthly with 30-day recency. EDMs offer deep clinical data models curated by disease including histologic information, detailed treatment and testing details, and scientifically validated endpoints like real-world progression and mortality.

[Download the fact sheet](https://page.flatiron.com/edm-fact-sheet-download) [Contact us](https://flatiron.com/contact/real-world-evidence/horizon-datascapes)

## 22 disease-specific data models

EDMs contain a combination of structured and more sophisticated abstracted, derived, and extracted data elements for 22 different cancer types:

---

- Acute myeloid leukemia
- Early breast cancer
- Metastatic breast cancer
- Chronic lymphocytic leukemia
- Metastatic colorectal cancer
- Diffuse large B-Cell lymphoma
- Advanced endometrial cancer
- Follicular lymphoma
- Advanced gastric/esophageal cancer
- Advanced head and neck cancer
- Hepatocellular carcinoma
- Mantle cell lymphoma
- Advanced melanoma
- Multiple myeloma
- Early non-small cell lung cancer
- Advanced non-small cell lung cancer
- Ovarian cancer
- Metastatic pancreatic cancer
- Metastatic prostate cancer
- Metastatic renal cell carcinoma
- Small cell lung cancer
- Advanced urothelial carcinoma

[Contact us to learn more](https://flatiron.com/contact/real-world-evidence/horizon-datascapes)

## Multinational datasets

Our multinational datasets contain a combination of structured and unstructured data elements for the below cancer types with additional indications planned for 2025 based on customer demand. Ex-US and multi-country data is available via our Trusted Research Environment, ensuring full compliance with local regulatory requirements including GDPR and APPI.

|  | UK | Germany | Japan |
| --- | --- | --- | --- |
| Breast cancer |  |  |  |
| Non-small cell lung cancer |  |  |  |
| Prostate cancer |  |  |  |
| Colorectal cancer |  |  |  |
| Gastric cancer |  |  |  |
| Diffuse large B-cell lymphoma |  |  |  |
| Small-cell lung cancer |  |  |  |
| Bladder cancer |  |  |  |
| Multiple myeloma |  |  |  |

[Contact us to learn more](https://flatiron.com/contact/real-world-evidence/multinational-data)

## Industry-leading real-world data

### 400K+

### de-identified patient records included in EDMs

### 20+

### Leading biopharma organizations subscribed to EDMs

### 30 days

### EDMs are refreshed monthly with 30-day recency

### 500+

### peer-reviewed publications using Flatiron's real-world data, including over 60 in top-tier journals

## Get in touch

Learn more about Enhanced Datamarts.

[Contact us to get started](https://flatiron.com/contact/real-world-evidence/horizon-datascapes)